Tarapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 13

Tarapeutics General Information

Description

Developer of therapeutic drug candidates based on advanced delivery technologies intended to treat cancer and other chronic diseases. The company offers a research and development pipeline that includes targeted drug candidates, platform technologies for precision delivery at the cellular and molecular level, and preclinical development capabilities focused on oncology and chronic illness, enabling pharmaceutical partners, clinical researchers, and healthcare stakeholders to address unintended systemic effects.

Contact Information

Website
www.tarapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5th Floor, Comprehensive Building, No. 35 Kaiyuan Avenue, Mohekou Town
  • Huaishang District, Bengbu
  • Bangbu, Anhui 233316
  • China
+86 0552
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 5th Floor, Comprehensive Building, No. 35 Kaiyuan Avenue, Mohekou Town
  • Huaishang District, Bengbu
  • Bangbu, Anhui 233316
  • China
+86 0552

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tarapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 12-Dec-2025 Completed Generating Revenue
7. Later Stage VC 23-Jan-2025 Completed Generating Revenue
6. Secondary Transaction - Private 26-Aug-2024 Completed Generating Revenue
5. Early Stage VC 11-Jan-2024 Completed Generating Revenue
4. Early Stage VC 03-Jan-2023 Completed Generating Revenue
3. Early Stage VC 28-Feb-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 22-Jul-2021 $15.4M $15.4M Completed Generating Revenue
1. Early Stage VC 07-Jan-2021 Completed Generating Revenue
To view Tarapeutics’s complete valuation and funding history, request access »

Tarapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tarapeutics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kangcheng Capital Growth/Expansion Minority
Anhui Provincial Emerging Industry Investment Government Minority
Qihang Capital Venture Capital Minority
ChemExpress Corporation Minority
Hefei Hi-Tech VC Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Tarapeutics FAQs

  • When was Tarapeutics founded?

    Tarapeutics was founded in 2019.

  • Where is Tarapeutics headquartered?

    Tarapeutics is headquartered in Bangbu, China.

  • What is the size of Tarapeutics?

    Tarapeutics has 4 total employees.

  • What industry is Tarapeutics in?

    Tarapeutics’s primary industry is Drug Discovery.

  • Is Tarapeutics a private or public company?

    Tarapeutics is a Private company.

  • What is Tarapeutics’s current revenue?

    The current revenue for Tarapeutics is .

  • How much funding has Tarapeutics raised over time?

    Tarapeutics has raised $15.4M.

  • Who are Tarapeutics’s investors?

    Kangcheng Capital, Anhui Provincial Emerging Industry Investment, Qihang Capital, ChemExpress, and Hefei Hi-Tech VC are 5 of 13 investors who have invested in Tarapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process